Segments of Operations - Schedule of Reportable Operating Segments Based on Net Sales and Operating Loss (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
|||||||||||||||
| Schedule of Reportable Operating Segments Based on Net Sales and Operating Loss [Line Items] | |||||||||||||||||||
| Revenues | $ 4,156 | $ 3,040 | $ 8,467 | $ 5,855 | |||||||||||||||
| Cost of revenues | 7,135 | 6,280 | 14,034 | 12,144 | |||||||||||||||
| Cost of revenues – Impairment of intangible assets | 40,695 | 40,695 | |||||||||||||||||
| Segment gross profit (loss) | (43,674) | (3,240) | (46,262) | (6,289) | |||||||||||||||
| Research and development, net | 4,707 | 4,834 | 9,505 | 9,812 | |||||||||||||||
| Sales and marketing | 1,900 | 1,239 | 4,064 | 2,178 | |||||||||||||||
| General and administrative | 5,444 | 5,127 | 10,684 | 10,265 | |||||||||||||||
| Other segment items | (248) | [1] | 51 | [2] | (480) | [3] | 37 | [2] | |||||||||||
| Segment operating loss | (55,477) | (14,491) | (70,035) | (28,581) | |||||||||||||||
| Financial income (expense), net | (61) | (149) | 308 | 616 | |||||||||||||||
| Loss before taxes on income | (55,538) | (14,640) | (69,727) | (27,965) | |||||||||||||||
| Depreciation expense | 314 | 299 | 629 | 586 | |||||||||||||||
| Amortization expense | 2,505 | 2,653 | 5,009 | 5,306 | |||||||||||||||
| Stock based compensation | 869 | 1,111 | 1,710 | 2,277 | |||||||||||||||
| Total Assets | 91,185 | 184,232 | 91,185 | 184,232 | $ 162,165 | ||||||||||||||
| Expenditures for segment’s assets | 2,761 | 1,579 | |||||||||||||||||
| Nanox. ARC [Member] | |||||||||||||||||||
| Schedule of Reportable Operating Segments Based on Net Sales and Operating Loss [Line Items] | |||||||||||||||||||
| Revenues | 162 | 221 | 329 | 254 | |||||||||||||||
| Cost of revenues | 1,948 | 1,961 | 3,713 | 3,570 | |||||||||||||||
| Cost of revenues – Impairment of intangible assets | |||||||||||||||||||
| Segment gross profit (loss) | (1,786) | (1,740) | (3,384) | (3,316) | |||||||||||||||
| Research and development, net | 3,565 | 3,759 | 7,253 | 7,546 | |||||||||||||||
| Sales and marketing | 1,445 | 1,066 | 3,175 | 1,885 | |||||||||||||||
| General and administrative | 4,563 | 4,322 | 9,037 | 8,522 | |||||||||||||||
| Other segment items | (247) | [1] | 51 | [2] | (507) | [3] | 37 | [2] | |||||||||||
| Segment operating loss | (11,112) | (10,938) | (22,342) | (21,306) | |||||||||||||||
| Depreciation expense | 286 | 270 | 576 | 530 | |||||||||||||||
| Amortization expense | |||||||||||||||||||
| Stock based compensation | 664 | 882 | 1,310 | 1,817 | |||||||||||||||
| Total Assets | 67,551 | 111,972 | 67,551 | 111,972 | |||||||||||||||
| Expenditures for segment’s assets | 2,761 | 1,569 | |||||||||||||||||
| Radiology Services [Member] | |||||||||||||||||||
| Schedule of Reportable Operating Segments Based on Net Sales and Operating Loss [Line Items] | |||||||||||||||||||
| Revenues | 2,950 | 2,723 | 6,055 | 5,328 | |||||||||||||||
| Cost of revenues | 2,077 | 2,242 | 4,785 | 4,402 | |||||||||||||||
| Cost of revenues – Impairment of intangible assets | |||||||||||||||||||
| Segment gross profit (loss) | 873 | 481 | 1,270 | 926 | |||||||||||||||
| Research and development, net | 28 | 36 | 64 | 65 | |||||||||||||||
| Sales and marketing | 56 | 110 | 265 | 208 | |||||||||||||||
| General and administrative | 458 | 734 | 919 | 1,606 | |||||||||||||||
| Other segment items | [1] | [2] | [3] | [2] | |||||||||||||||
| Segment operating loss | 331 | (399) | 22 | (953) | |||||||||||||||
| Depreciation expense | 3 | 2 | 4 | 4 | |||||||||||||||
| Amortization expense | 495 | 657 | 990 | 1,314 | |||||||||||||||
| Stock based compensation | 157 | 186 | 302 | 370 | |||||||||||||||
| Total Assets | 19,174 | 18,774 | 19,174 | 18,774 | |||||||||||||||
| Expenditures for segment’s assets | 10 | ||||||||||||||||||
| AI and Software Solutions [Member] | |||||||||||||||||||
| Schedule of Reportable Operating Segments Based on Net Sales and Operating Loss [Line Items] | |||||||||||||||||||
| Revenues | 1,044 | [4] | 96 | 2,083 | [5] | 273 | |||||||||||||
| Cost of revenues | 3,110 | 2,077 | 5,536 | 4,172 | |||||||||||||||
| Cost of revenues – Impairment of intangible assets | 40,695 | 40,695 | |||||||||||||||||
| Segment gross profit (loss) | (42,761) | (1,981) | (44,148) | (3,899) | |||||||||||||||
| Research and development, net | 1,114 | 1,039 | 2,188 | 2,201 | |||||||||||||||
| Sales and marketing | 399 | 63 | 624 | 85 | |||||||||||||||
| General and administrative | 423 | 71 | 728 | 137 | |||||||||||||||
| Other segment items | (1) | [1] | [2] | 27 | [3] | [2] | |||||||||||||
| Segment operating loss | (44,696) | (3,154) | (47,715) | (6,322) | |||||||||||||||
| Depreciation expense | 25 | 27 | 49 | 52 | |||||||||||||||
| Amortization expense | 2,009 | 1,996 | 4,019 | 3,992 | |||||||||||||||
| Stock based compensation | 48 | 43 | 98 | 90 | |||||||||||||||
| Total Assets | $ 4,460 | $ 53,486 | 4,460 | $ 53,486 | |||||||||||||||
| Expenditures for segment’s assets | |||||||||||||||||||
| |||||||||||||||||||
| X | ||||||||||
- Definition Cost of revenues – Impairment of intangible assets. No definition available.
|
| X | ||||||||||
- Definition The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after tax, of expense for award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of asset recognized for present right to economic benefit. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The net cash outflow or inflow from purchases, sales and disposals of property, plant and equipment and other productive assets, including intangibles. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|